EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSSLUG00000016390
Gene Symbol: PSMD8
1 Cross references
211 Possible Orthologues:

Proteasome Subunit Alpha Type-3-Like

Ensembl ID : ENSSLUG00000022386
Gene Symbol: PSMA3
3 Cross references
237 Possible Orthologues:

Proteasome Subunit Alpha Type-4

Ensembl ID : ENSSLUG00000023649
Gene Symbol: LOC116060311
3 Cross references
186 Possible Orthologues:

Proteasome Subunit Alpha Type-6

Ensembl ID : ENSSLUG00000012820
Gene Symbol: LOC116041976
3 Cross references
278 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSSLUG00000005233
Gene Symbol: PSMB11
1 Cross references
169 Possible Orthologues:

Proteasome Subunit Beta Type-7-Like

Ensembl ID : ENSSLUG00000017834
Gene Symbol: LOC116041466
3 Cross references
171 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSSLUG00000005387
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSSLUG00000004590
Gene Symbol: LOC116065981
3 Cross references
209 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSSLUG00000012164
Gene Symbol: PRKCB
3 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSSLUG00000016231
Gene Symbol: LOC116057228
3 Cross references
223 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSSLUG00000009198
Gene Symbol: PRKCD
1 Cross references
203 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSSLUG00000013140
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).